BRIMONIDINE
| Product name | BRIMONIDINE |
| CAS No. | 59803-98-4 |
| Molecular Structure | .jpg) |
| Uasage | |
|
Molecular Formula:C11H10BrN5
Synonyms:5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline; AGN 190342; Bromoxidine; UK 14304-18; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine; 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine; 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-;
Appearance:Yellow Solid
Molecular Weight:292.13
Density:1.82 g/cm3
Boiling Point:432.6 ºC
Melting Point:207.5℃
Flash Point:215.4 ºC
Storage Temperature:Keep container tightly closed.
Refractive index:1.798
Biological Activity:Full α 2 adrenergic agonist. Centrally active following systemic administration in vivo . Also available as part of the α 2 -Adrenoceptor Tocriset? and Mixed Adrenergic Tocriset
Stability:Stable at normal temperatures and pressures.
Usage:a2-Adrenoceptor agonist. Antiglaucoma
|
|
.Remark: products patented are for R&D only and are permitted under 35 USC 271(e).
.Patent products cannot be offered to the countries where patent law is in force.
Final responsibility lies with the buyer exclusively.
Contact Us: Pharmchem Devision:info@afinechem.com
Finechem Devision:sales@afinechem.com
